Eventus Diagnostics is an emerging life sciences company developing accurate and cost-effective blood tests that measure cancer-specific autoantibodies. The company's first products, the Octava Pink and Octava Blue tests, provide information that enables women and their physicians to better assess the validity of their mammography screening results for the improved diagnosis of breast cancer.
The Octava Pink test is designed to provide additional diagnostic information to help physicians confirm true negative mammography findings with high accuracy, while helping to identify the presence of cancer in cases where mammography produces a false negative result and cancer is actually present.
The Octava Blue test is designed for use in conjunction with screening mammograms to provide additional diagnostic information to help physicians confirm true abnormal mammography results with high accuracy, while also helping to reduce the large number of unnecessary biopsies caused by false alarms. Octava Blue has the potential to help reduce the number of unneeded biopsies by at least 50%, saving many women the anxiety and invasiveness of the biopsy procedure while also reducing unnecessary medical costs.